当前位置: 首页 > 期刊 > 《医学信息》 > 201419
编号:13683165
麝香保心丸对急性冠脉综合症患者炎症因子及心脏事件的影响与研究
http://www.100md.com 2014年5月14日 张秋 孙诚 孙明旭
C反应蛋白,白介素6,血清炎症,冠脉病变
第1页

    参见附件。

     摘要:研究显示血清炎症反应标志物C反应蛋白(CRP)、白介素6(IL-6)的水平与冠状动脉粥样硬化有关[1]。CRP、IL-6水平增高是造成急性冠脉综合症(ACS)患者病情恶化的主要原因之一,能够反映冠脉病变的严重程度。本文旨在观察ACS患者应用麝香保心丸治疗前后血清炎症反应标志物CRP、IL-6水平的变化,以进一步探讨麝香保心丸在冠心病治疗中的作用。

    关键词:C反应蛋白;白介素6;麝香保心丸;血清炎症;冠脉病变

    Effects of Acute Coronary Syndrome Factor and Cardiac Events in Patients with Inflammation and of Shexiangbaoxin Pill

    ZHANG Qiu,SUN Cheng,SUN Ming-xu

    (Department of Internal Medicine, Ningyang County Gangcheng Town Center Hospital, Tai'an 271416,Shandong,China)

    Abstract:To study the serum inflammatory markers of C reactive protein (CRP), interleukin 6 (IL-6)levels and coronary atherosclerosis [1]. CRP, the increased level of IL-6 is the cause of acute coronary syndrome(ACS) is one of the main causes of deterioration in patients with severe, can reflect the degree of coronary artery disease. This paper is to investigate the effects of ACStreated with Shexiang Baoxin Pill changes of seruminflammatory markers CRP, IL-6 before and after treatment,in order to further explore the musk effect of Baoxin Pill in the treatment of coronary heart disease ......

您现在查看是摘要介绍页,详见PDF附件